At the Company's June 1, 2022 annual stockholders meeting the company is going to seek a reverse stock split...
Recent CLXT News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/19/2024 08:10:59 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/19/2024 08:08:25 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/19/2024 08:06:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/21/2024 08:52:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/21/2024 08:07:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 10:01:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 09:47:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 12:15:59 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/02/2024 12:07:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 09:35:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 04:23:29 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/12/2023 01:01:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 12:16:51 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/12/2023 12:01:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:31:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:32:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:31:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:09:06 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/02/2023 09:24:40 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/25/2023 08:52:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 08:16:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 09:22:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2023 08:58:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 02:29:35 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM